As an alternative, many groups have used NK-92 cells, an interleukin-2 (IL-2) -dependant human NK cell line, that can be easily expanded, engineered, and has demonstrated sustainable cytotoxicity against many cancer types [41–45]. The gene discussed is IL2; the disease is cancer.